Clinical Trial Update: A Study To Evaluate the Safety and Efficacy of Human Neural Stem Cells for Parkinson's Disease Patient [Phase 2, Phase 3]

View source ↗

Summary

A study evaluating the safety and efficacy of human neural stem cells for Parkinson's disease, currently in Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Human neural stem cells (neural stem cells)

Snippet

Sponsor: Second Affiliated Hospital of Soochow University | Conditions: Parkinson Disease | Phase 2, Phase 3 | Status: UNKNOWN